The one thing that could boost the stock price in a hurry is if palladium were to shoot up $50/day for several days and stay above $1000. Perhaps a billionaire or two to buy up the available stockpiles.
8% market share, losing money and more competition with deep pockets in play, what's not to like. Perhaps it's climbing on speculation that microsoft might snap them up.
I would have thought they could at least get compassionate use status for vetrinary medicine, but I don't really know the rules governing that arena.
I don't understand why they haven't suspended the dividend until they get the company profitable. Seems like this should have been done a year ago. Sure the stock price would take more of a hit, but if you aren't making money, you don't pay a dividend.
I'm sure the vast majority of customers are women, but why not market to both sexes?
I think they're missing a huge market by not targeting men as well. There's nothing to stop men from purchasing, but why make them feel like girly men for buying product. Market to all the Everdeep pockets.
I'm wondering if it would make sense for Tesla to buy the safest 'motorcycle' designed and prototyped down the road in San Francisco. It seems to me it would fit in with Tesla's future stable of offerings very nicely and be the more affordable option for those seeking cool, fun, non-polluting personal transportation.
I would assume Elon is aware of the C-1 that's in development.
Unfortunately I'm not a Tesla investor or Model S owner. At this point, just a Musketeer who appreciates the efforts and talents of Elon.
I read about the thorium car idea and thought it sounded promising.
In the meantime let's make the roads safer for bicyclists.
We have to stop burning so much stuff just to keep warm and get around. It's highly inefficient and it's hurting our primary life support system.
As far as reducing wrinkles which product line will do a better job? Face it...so many skin products make it quite confusing. They were doing pretty well with Algenist and now a new wrinkle in their strategy. Is Everdeep just the poor girl's alternative? All these choices would put a furrow in any brow. We need some clarity.
I guess the test would be to do half your face with algenist and the other with everdeep.
We're talking about less than 10 grams or 1/3 of an ounce that powers a car for 100 years!, not a nuclear power plant. Simple to shield. It's a matter of psychology... people drive around now with the risk of getting smashed by somebody who is smashed. We have fuel tanks of explosive material and potentially combustible batteries and we think nothing of it. But ooooh, 8 grams of thorium in a shielded protective box....no way.
A lot of work is outsourced to India...call centers, accounting, software programming, tech support...you name it. Where have you been?
Are you saying you have never had to call for tech support and talk to someone in India? There a probably at least 100 million English speakers in India.
Btw, let's not forget one of the latest industries outsourcing to India...clinical drug and medical device trials. ;-)
India has its own space agency too.
A little bit has changed since Mark Twain's time.
No batteries, no plugging in or charging stations needed. A thorium powered car would literally run for a lifetime! Perhaps the 2020 or 2025 model.
It's not hard to shield for radiation either.
The Indian middle class is enough of a market. According to one source, the middle class in India currently numbers some 50 million people, but by 2025 will have expanded dramatically to 583 million people—some 41 percent of the population.
Another reason to start in India is that it would be a good place to manufacture hemopurifiers.
It's the only place I'm aware of that Aethlon at least as a toe hold even if it's only by a toenail.
$1.50/share or Focalin...which comes first?
I still think they ought to name a drug after their CFO - Rampertab who according to Forbes made $265K in 2011. Gosh, I would have kept track of their losses for $40K/year. I guess it is a challenging job... you not only have to know how to subtract but also how to multiply by negative numbers
As super hubba bubba points out: "The Agency will not disclose the identity of the applicant."
Therefore it seems to me that one has to believe that a company has filed an application with FDA since there is no way to verify they have.
Bigblue, thank you so much for your detailed summary. I was the one making a gross error in multiplying. I need to start triple checking myself now that I'm carrying around an old brain.
I must have done the math correctly at some point, because I actually bought in, albeit at a bit higher prices. You wouldn't think that management would sink so many millions into a black hole with no hope of return on investment. I feel more hopeful about my investment now.
If you call the FDA, they will not confirm that any company has filed an application for a drug approval.
So, theoretically a comapany with giant balls could pretend to have drugs under review. Not saying that is the case here, but ain't that fascinating?